Legend Biotech Corporation (LEGN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 11:49AM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 8.28B |
| Enterprise Value | 7.31B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 23.89 |
| Price/Book (mrq) | 7.11 |
| Enterprise Value/Revenue | 21.33 |
| Enterprise Value/EBITDA | -15.34 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.12 |
| 52-Week Change 3 | -31.73% |
| S&P500 52-Week Change 3 | 28.04% |
| 52 Week High 3 | 77.32 |
| 52 Week Low 3 | 42.08 |
| 50-Day Moving Average 3 | 52.12 |
| 200-Day Moving Average 3 | 60.66 |
Share Statistics
| Avg Vol (3 month) 3 | 1.03M |
| Avg Vol (10 day) 3 | 853.19k |
| Shares Outstanding 5 | 182.28M |
| Implied Shares Outstanding 6 | 182.29M |
| Float 8 | 159.53M |
| % Held by Insiders 1 | 1.32% |
| % Held by Institutions 1 | 49.03% |
| Shares Short (Apr 30, 2024) 4 | 13.28M |
| Short Ratio (Apr 30, 2024) 4 | 12.04 |
| Short % of Float (Apr 30, 2024) 4 | 14.05% |
| Short % of Shares Outstanding (Apr 30, 2024) 4 | 7.30% |
| Shares Short (prior month Mar 28, 2024) 4 | 9.99M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Mar 31, 2024 |
Profitability
| Profit Margin | -135.92% |
| Operating Margin (ttm) | -125.40% |
Management Effectiveness
| Return on Assets (ttm) | -18.25% |
| Return on Equity (ttm) | -51.28% |
Income Statement
| Revenue (ttm) | 342.8M |
| Revenue Per Share (ttm) | 1.90 |
| Quarterly Revenue Growth (yoy) | 158.70% |
| Gross Profit (ttm) | N/A |
| EBITDA | -425.38M |
| Net Income Avi to Common (ttm) | -465.95M |
| Diluted EPS (ttm) | -2.58 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.3B |
| Total Cash Per Share (mrq) | 3.57 |
| Total Debt (mrq) | 334.69M |
| Total Debt/Equity (mrq) | 28.75% |
| Current Ratio (mrq) | 5.66 |
| Book Value Per Share (mrq) | 6.39 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -238.54M |
| Levered Free Cash Flow (ttm) | -264.06M |
© 2024 Yahoo. All rights reserved.